Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

Kojima M, Ishii G, Atsumi N, Fujii S, Saito N, Ochiai A.

Cancer Sci. 2008 Aug;99(8):1578-83. doi: 10.1111/j.1349-7006.2008.00849.x.

2.

CD133 expression and the prognosis of colorectal cancer: a systematic review and meta-analysis.

Chen S, Song X, Chen Z, Li X, Li M, Liu H, Li J.

PLoS One. 2013;8(2):e56380. doi: 10.1371/journal.pone.0056380. Epub 2013 Feb 11. Review.

3.

Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review.

Wen L, Chen XZ, Yang K, Chen ZX, Zhang B, Chen JP, Zhou ZG, Mo XM, Hu JK.

PLoS One. 2013;8(3):e59154. doi: 10.1371/journal.pone.0059154. Epub 2013 Mar 22. Review. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/80c50c32-16b8-4099-98e4-af72154192b3.

4.

Cyclooxygenase, cancer stem cells and DNA methylation play important roles in colorectal carcinogenesis.

Tsujii M.

Digestion. 2013;87(1):12-6. doi: 10.1159/000343898. Epub 2013 Jan 21. Review.

5.

Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis.

Zhou Q, Chen A, Song H, Tao J, Yang H, Zuo M.

Int J Clin Exp Med. 2015 Mar 15;8(3):3080-8. eCollection 2015. Review.

Supplemental Content

Support Center